TC Biopharm (Holdings) Plc (TCBP )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol TCBP
- Company TC Biopharm (Holdings) Plc
- Price $0.36
- Changes Percentage 14.1
- Change 0.0445
- Day Low $0.31
- Day High $0.37
- Year High $32.7
- Year Low $0.25
- Market Cap $1,112
- Price Avg 50 EMA (D) $0.52
- Price Avg 200 EMA (D) $5.68
- Exchange NASDAQ
- Volume 567,501
- Average Volume 1,650,148
- Open $0.31
- Previous Close $0.32
- EPS -231.15
- PE 0.00
- Earnings Announcement 2025-02-26 12:00:00
- Shares Outstanding $618,141
Company brief: TC BIOPHARM (HOLDINGS) PLC (TCBP )
- Healthcare
- Biotechnology
- Mr. Bryan L. Kobel
- https://www.tcbiopharm.com
- GB
- N/A
- 02-11-2022
- US87807D4007
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.